The Phase 3 GENESIS trial is aimed at evaluating the safety, tolerability and efficacy of the combination treatment of BL-8040...
Read more
Boehringer Ingelheim and pharmaceutical company Pharmaxis announce that Boehringer Ingelheim has initiated a European and North American Phase IIa trial...
Read more
Astellas Pharma Inc. announced that the first patient was dosed in the registrational Phase 3 MORPHO trial of gilteritinib, the...
Read more
Bristol-Myers Squibb Company announced topline results from the CheckMate -214 trial investigating Opdivo (nivolumab) in combination with Yervoy (ipilimumab) versus...
Read more
CARsgen Therapeutics (CARsgen), a global leader in developing chimeric antigen receptor T-cell (CAR-T cell) therapies for solid tumors announced its...
Read more
Motif Bio plc ,the clinical stage biopharmaceutical company specialising in developing novel antibiotics, announced that the last patient has completed...
Read more
Intercept Pharmaceuticals, Inc. , a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral...
Read more
Teva Pharmaceutical Industries Ltd. and Xenon Pharmaceuticals Inc. announce top-line results in a Phase II study of topical TV-45070 in...
Read more
DelMar Pharmaceuticals , a biopharmaceutical company focused on the development of new cancer therapies announced that the HGRAC, has approved...
Read more
DelMar Pharmaceuticals , a biopharmaceutical company focused on the development of new cancer therapies, announced it has received Institutional Review...
Read more
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
